JSE gains on Covid-19 vaccine optimism
US officials have said that vaccination could be rolled out by mid-December
BL PREMIUM
24 November 2020 – 11:13
The JSE was firmer on Tuesday, with global peers mixed as investors pinned hopes for economic revival on Covid-19 vaccines.
The vaccine developed by AstraZeneca and Oxford University is the third major trial to report success after US-based Moderna and Pfizer with Germany’s BioNTech, sending pandemic-weary investors to take on risk in hopes of a swift economic recovery…
Source: businesslive.co.za